This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is NOT typically covered under Level II codes? a. Drugs b. Non-physician ... (Read 172 times)

DelorasTo

  • Hero Member
  • *****
  • Posts: 548
Which of the following is NOT typically covered under Level II codes?
 
  a. Drugs
  b. Non-physician providers
  c. Some physician services for Medicare and Medicaid
  d. Major surgery

Question 2

Which of the following parties is not likely to review the medical record?
 
  A. Insurance auditors
  B. A consultant
  C. A vendor
  D. The patient



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

efwsefaw

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

d

Answer to Question 2

C.A vendor




DelorasTo

  • Member
  • Posts: 548
Reply 2 on: Jun 25, 2018
YES! Correct, THANKS for helping me on my review


mcarey591

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The most dangerous mercury compound, dimethyl mercury, is so toxic that even a few microliters spilled on the skin can cause death. Mercury has been shown to accumulate in higher amounts in the following types of fish than other types: swordfish, shark, mackerel, tilefish, crab, and tuna.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library